Refreshing results…
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
Download from www.nature.comActivating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
Download from www.nature.comA Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer
Download from aacrjournals.orgTRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors
Download from doi.orgA Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105
UploadMissing publications? Search for publications with a matching author name.